Summary
HCA Healthcare, Inc. (HCA) filed a Form 8-K on April 30, 2002, primarily to disclose information related to the issuance and sale of $500 million in aggregate principal amount of its 6.95% Notes due 2012. This filing indicates that HCA has successfully raised significant capital through debt offerings, which could be used for various corporate purposes such as strategic initiatives, acquisitions, or refinancing existing debt. The details provided include the underwriting agreement and supplemental indentures, which outline the terms and conditions governing these new notes. Investors should note that the issuance of new debt increases HCA's leverage. While this can be a tool for growth, it also adds to the company's fixed interest obligations. The 6.95% interest rate on these notes due in 2012 suggests a medium-term maturity for this portion of the company's debt. The filing also incorporates by reference several prior agreements, underscoring the ongoing nature of HCA's capital management and debt structure.
Key Highlights
- 1HCA issued and sold $500 million in aggregate principal amount of 6.95% Notes due 2012.
- 2The issuance of these notes was conducted under the Securities Act of 1933, as amended.
- 3The filing includes the underwriting agreement dated April 23, 2002, detailing the terms of the sale with underwriters.
- 4Several supplemental indentures, governing the terms of the notes with the Trustee, are referenced and incorporated by filing.
- 5The specific notes issued consist of two tranches: one for $400 million and another for $100 million, both bearing a 6.95% interest rate and maturing in 2012.
- 6This debt issuance is a significant capital raise event, impacting HCA's balance sheet and leverage ratios.